| Primary |
| Drug Use For Unknown Indication |
49.1% |
| General Anaesthesia |
18.9% |
| Lung Disorder |
7.5% |
| Prophylaxis |
7.5% |
| Sedation |
7.5% |
| Agitation |
3.8% |
| Depression |
1.9% |
| Labour Pain |
1.9% |
| Tachypnoea |
1.9% |
|
| Acute Generalised Exanthematous Pustulosis |
11.1% |
| Cardiac Arrest |
11.1% |
| Drug Exposure During Pregnancy |
11.1% |
| Multiple Congenital Abnormalities |
11.1% |
| Persistent Left Superior Vena Cava |
11.1% |
| Pregnancy |
11.1% |
| Respiratory Depression |
11.1% |
| Snoring |
11.1% |
| Vater Syndrome |
11.1% |
|
| Secondary |
| Anaesthesia |
22.4% |
| General Anaesthesia |
17.5% |
| Induction Of Anaesthesia |
13.1% |
| Maternal Exposure Timing Unspecified |
7.0% |
| Product Used For Unknown Indication |
5.9% |
| Drug Use For Unknown Indication |
5.6% |
| Epidural Anaesthesia |
3.4% |
| Pain |
3.2% |
| Surgery |
2.9% |
| Infection |
2.4% |
| Antibiotic Prophylaxis |
2.2% |
| Abdominal Pain |
1.9% |
| Sedation |
1.9% |
| Local Anaesthesia |
1.7% |
| Postoperative Care |
1.7% |
| Therapeutic Procedure |
1.7% |
| Premedication |
1.5% |
| Prophylaxis |
1.5% |
| Vulvovaginitis Streptococcal |
1.4% |
| Hysterectomy |
1.2% |
|
| Anaphylactic Shock |
18.3% |
| Shock |
14.4% |
| Urticaria |
12.5% |
| Tachycardia |
6.7% |
| Rash |
4.8% |
| Circulatory Collapse |
3.8% |
| Hypotension |
3.8% |
| Pancreatitis Acute |
3.8% |
| Transaminases Increased |
3.8% |
| Weight Decreased |
3.8% |
| Cholestasis |
2.9% |
| Oxygen Saturation Decreased |
2.9% |
| Paresis |
2.9% |
| Respiratory Gas Exchange Disorder |
2.9% |
| Therapeutic Response Prolonged |
2.9% |
| Anaemia |
1.9% |
| Disseminated Intravascular Coagulation |
1.9% |
| Erythema Multiforme |
1.9% |
| Generalised Erythema |
1.9% |
| Guillain-barre Syndrome |
1.9% |
|
| Concomitant |
| Induction Of Anaesthesia |
15.4% |
| Anaesthesia |
14.7% |
| Product Used For Unknown Indication |
11.5% |
| Drug Use For Unknown Indication |
10.0% |
| Prophylaxis |
6.8% |
| Unevaluable Event |
5.9% |
| Sedation |
4.6% |
| Thrombosis Prophylaxis |
4.2% |
| Liver Transplant |
3.1% |
| Renal Transplant |
2.8% |
| Respiratory Tract Infection |
2.7% |
| Analgesia |
2.4% |
| General Anaesthesia |
2.2% |
| Pain |
2.2% |
| Septic Shock |
2.2% |
| Neuromuscular Blockade Reversal |
2.0% |
| Epidural Anaesthesia |
1.9% |
| Hypertension |
1.9% |
| Supplementation Therapy |
1.9% |
| Haemorrhagic Disorder |
1.6% |
|
| Anaesthetic Complication |
9.1% |
| Pharmaceutical Product Complaint |
9.1% |
| Renal Failure Acute |
6.8% |
| Septic Shock |
6.8% |
| Tachycardia |
6.8% |
| Thrombocytopenia |
6.8% |
| Venous Thrombosis Limb |
5.7% |
| Hypotension |
4.5% |
| Respiratory Failure |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Urticaria |
4.5% |
| Coagulopathy |
3.4% |
| Overdose |
3.4% |
| Pancreatitis |
3.4% |
| Pancreatitis Acute |
3.4% |
| Rhabdomyolysis |
3.4% |
| Skin Test Positive |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Uterine Atony |
3.4% |
| Ventricular Fibrillation |
3.4% |
|
| Interacting |
| Depressive Symptom |
25.0% |
| Nausea |
25.0% |
| Parathyroid Gland Operation |
25.0% |
| Surgery |
25.0% |
|
| Serotonin Syndrome |
100.0% |
|
